Samsung Biologics launches biopharmaceutical platform S-HiCon

The platform aims to proactively recognise unintended pH changes, bolster formulation stability, and reduce viscosity to ensure efficacy and optimise drug delivery. Credit: Diane Serik on Unsplash.